DSM takes a string of sizable steps to expand its gut health offerings

November 13, 2018 | Case Study

DSM has already had gut health products within its portfolio for some time (e.g., Culturelle), but starting in late 2017, the company made serious moves to bolster its presence within the area. In December 2017, it acquired BioCare Copenhagen, a Danish company that specializes in the production of white-label probiotics and microbial actives. Shortly thereafter, DSM led a Series A funding round for Prenexus Health (Lux Take: Positive), a developer of a xylooligosaccharide (XOS) prebiotic derived from high-fiber sugarcane. In addition, DSM formed a distribution partnership with Prenexus Health, planning to market and sell the prebiotic under the name AmpliVida XOS after Prenexus completes construction of its manufacturing facility.

About Lux Research

Lux Research is a leading provider of tech-enabled research and advisory solutions, helping clients drive growth through technology innovation. A pioneer in the research industry, Lux uniquely combines technical expertise and business insights with a proprietary intelligence platform, using advanced analytics and data science to surface true leading indicators. With quality data derived from primary research, fact-based analysis, and opinions that challenge traditional thinking, Lux clients are empowered to make more informed decisions today to ensure future success.

Already a Lux Client?

Sign In

Interested in Learning More?

Contact us to learn the benefits of becoming a Lux member.

Or call us now

For North America (Boston Headquarters)
+1 (617) 502-5300

For EMEA (Amsterdam)
+31 20 280 7900

For APAC (Singapore)
+65 6592-6978